logo
  

Cadence Design Systems Lifts FY22 Outlook; Shares Up 5%

While reporting its first-quarter results on Monday, Cadence Design Systems (CDNS) lifted its outlook for the full year 2022. The stock gained over 5% in extended session.

For the full year 2022, the company now expects earnings of $2.51 to $2.59 per share, adjusted earnings of $3.89 to $3.97 per share and revenues of $3.395 billion to $3.435 billion.

Previously, the company expected earnings of $2.46 to $2.56 per share, adjusted earnings of $3.70 to $3.80 per share on revenues of $3.32 billion to $3.38 billion.

Analysts polled by Thomson Reuters currently estimate earnings of $3.80 per share and revenues of $3.36 billion. Analysts' estimates typically exclude one-time items.

For the second quarter, the company expects revenues of $825 million to $845 million, earnings of $0.59 to $0.63 per share and adjusted earnings of $0.95 to $0.99 per share. Analysts currently estimate earnings of $0.92 per share and revenues of $823.74 million for the quarter.

CDNS closed Monday's trading at $151.10, up $3.03 or 2.05%, on the Nasdaq. The stock further gained $8.30 or 5.49% in the after-hours trading.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Healthcare major Johnson & Johnson, which is in the middle of a talcum powder fiasco, said it is discontinuing talc-based JOHNSON'S Baby Powder globally in 2023. The company plans to transition to an all cornstarch-based baby powder portfolio. According to the company, the commercial decision to use cornstarch in all its baby powder products was made after conducting an assessment of its portfolio Walt Disney's streaming service Disney+ is rolling out its much-anticipated new ad-supported subscription plan for Disney+ in the U.S. as part of its bid to stem the loss and make its streaming business profitable after the services posted a hefty operating loss of more than $1 billion in the third quarter. It is also raising pricing for its bundled subscription plans with Hulu, ESPN+ and live TV. The U.S. Food and Drug Administration announced the intended availability of base powder to make around 6 million bottles of specialty formula from Mexico as part of its efforts to meet the nationwide supply shortage caused by Abbott Nutrition recall. Reckitt Nutrition/Mead Johnson Nutrition will send an initial shipment of 331 thousand pounds of base powder for PurAmino Hypoallergenic Formula.
Follow RTT